LCB-19

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLCB-19
Drug Alias NameVEGF inhibitor program (Interprotein/LegoChem Bioscience)LCB-19
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionVascular endothelial growth factor receptor antagonistsVascular endothelial growth factor inhibitors
TargetsVascular endothelial growth factorVascular endothelial growth factor receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth KoreaJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInterprotein Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLigaChem Biosciences IncInterprotein Corp
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A